Busse R, Bassenge E
Herz. 1982 Dec;7(6):388-405.
The effectiveness of organic nitrates in the therapy of angina pectoris can be explained from their direct relaxing action on vascular smooth muscle. At conventional dosage the most important action of nitrates is a pooling of blood in the large systemic venous capacitance vessels which leads to a decrease of central venous pressure and ventricular filling pressure. The resulting reduction in left ventricular volume lowers, at virtually constant arterial pressure, systolic wall tension and hence myocardial oxygen consumption. Only at higher dosage, is a distinct dilatation of systemic resistance vessels affected. The fundamental action of the "Ca antagonists", i.e. the inhibition of transmembrane calcium influx in the myocardium and the vascular smooth muscle, includes various beneficial effects for the treatment of angina pectoris. The lowering of myocardial oxygen consumption after application of calcium antagonist is mainly due 1. to the decrease in afterload of the left ventricle, caused by the relaxation of peripheral resistance vessels, 2. to the reduction in ventricular preload by a peripheral venodilation. By a direct inhibitory effect on the coronary vascular tone, coronary blood flow at rest in patients with angina pectoris increases. In addition, Ca antagonists are very efficacious in relieving angiospastic angina. The primary mode of action of beta-blocking drugs in angina pectoris affects, in contrast to the peripheral mechanisms of nitrates and Ca antagonists, is on the heart directly. By the reduction in the extent of exercise heart rate, the increase in cardiac output and, hence, the mean arterial pressure is also significantly lower during exercise under beta-blockade. Beta-blockers also depress the contractile state of myocardium. Therefore, the main factors of the myocardial oxygen consumption (mean arterial pressure, size of the left ventricle, contractility and heart rate) may be essentially influenced. By the decrease in heart rate and the longer diastolic period a better myocardial oxygen delivery results. Besides the immediate cardiac effects of beta-adrenergic blockade, a decline in peripheral resistance combined with a fall in blood pressure occur in hypertensive patients during long-term drug administration. Different hypotheses have been proposed in the last years to explain the antihypertensive mode of action of beta-blockers. Some possible mechanisms are discussed.
有机硝酸盐在心绞痛治疗中的有效性可通过其对血管平滑肌的直接舒张作用来解释。在常规剂量下,硝酸盐最重要的作用是使大量体循环静脉容量血管中的血液淤积,这导致中心静脉压和心室充盈压降低。在动脉压基本恒定的情况下,左心室容积的减小会降低收缩期壁张力,从而降低心肌耗氧量。只有在较高剂量时,才会影响体循环阻力血管的明显扩张。“钙拮抗剂”的基本作用,即抑制心肌和血管平滑肌中的跨膜钙内流,对心绞痛治疗具有多种有益效果。应用钙拮抗剂后心肌耗氧量的降低主要归因于:1. 外周阻力血管舒张导致左心室后负荷降低;2. 外周静脉扩张使心室前负荷降低。通过对冠状动脉血管张力的直接抑制作用,心绞痛患者静息时的冠状动脉血流量增加。此外,钙拮抗剂在缓解血管痉挛性心绞痛方面非常有效。与硝酸盐和钙拮抗剂的外周作用机制不同,β受体阻滞剂在心绞痛治疗中的主要作用方式是直接作用于心脏。通过降低运动时的心率幅度,心输出量增加,因此在β受体阻滞剂作用下运动时的平均动脉压也显著降低。β受体阻滞剂还会抑制心肌的收缩状态。因此,心肌耗氧量的主要因素(平均动脉压、左心室大小、收缩力和心率)可能会受到显著影响。由于心率降低和舒张期延长,心肌的氧输送情况得到改善。除了β肾上腺素能阻滞的直接心脏效应外,高血压患者在长期用药期间会出现外周阻力下降和血压降低。近年来提出了不同的假说来解释β受体阻滞剂的降压作用机制。文中讨论了一些可能的机制。